301 related articles for article (PubMed ID: 33103204)
1. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
Shabana A; Dholoo F; Banerjee P
Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
[TBL] [Abstract][Full Text] [Related]
2. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
3. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
Hu K; Mathew R
Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
[TBL] [Abstract][Full Text] [Related]
4. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
5. Cardiogenic shock: Inotropes and vasopressors.
Amado J; Gago P; Santos W; Mimoso J; de Jesus I
Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
[TBL] [Abstract][Full Text] [Related]
6. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
Levy B; Buzon J; Kimmoun A
Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
[TBL] [Abstract][Full Text] [Related]
7. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
Karami M; Hemradj VV; Ouweneel DM; den Uil CA; Limpens J; Otterspoor LC; Vlaar AP; Lagrand WK; Henriques JPS
J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32629772
[TBL] [Abstract][Full Text] [Related]
8. The medical treatment of cardiogenic shock: cardiovascular drugs.
De Backer D; Arias Ortiz J; Levy B
Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
[TBL] [Abstract][Full Text] [Related]
9. Inotropic agents in cardiogenic shock.
Polyzogopoulou E; Arfaras-Melainis A; Bistola V; Parissis J
Curr Opin Crit Care; 2020 Aug; 26(4):403-410. PubMed ID: 32496275
[TBL] [Abstract][Full Text] [Related]
10. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
[TBL] [Abstract][Full Text] [Related]
11. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
Rohm CL; Gadidov B; Ray HE; Mannino SF; Prasad R
Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
[TBL] [Abstract][Full Text] [Related]
12. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.
Belletti A; Castro ML; Silvetti S; Greco T; Biondi-Zoccai G; Pasin L; Zangrillo A; Landoni G
Br J Anaesth; 2015 Nov; 115(5):656-75. PubMed ID: 26475799
[TBL] [Abstract][Full Text] [Related]
13. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
Nandkeolyar S; Ryu R; Mohammad A; Cordero-Caban K; Abramov D; Tran H; Hauschild C; Stoletniy L; Hilliard A; Sakr A
J Cardiovasc Pharmacol; 2021 Sep; 78(3):336-345. PubMed ID: 34117179
[TBL] [Abstract][Full Text] [Related]
14. "Assessing the hemodynamic impact of various inotropes combination in patients with cardiogenic shock with Non-ST elevation myocardial infarction -the ANAPHOR study".
Sharma K; Charaniya R; Champaneri B; Bhatia S; Sharma V; Mansuri Z; Panakkal BJ; Thakkar H; Patel K
Indian Heart J; 2021; 73(5):572-576. PubMed ID: 34627571
[TBL] [Abstract][Full Text] [Related]
15. Role of medical management of cardiogenic shock in the era of mechanical circulatory support.
Blumer V; Marbach J; Veasey T; Kanwar M
Curr Opin Cardiol; 2022 May; 37(3):250-260. PubMed ID: 35612937
[TBL] [Abstract][Full Text] [Related]
16. Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry.
Lauridsen MD; Gammelager H; Schmidt M; Nielsen H; Christiansen CF
BMC Med Res Methodol; 2015 Mar; 15():23. PubMed ID: 25888061
[TBL] [Abstract][Full Text] [Related]
17. Vasopressors and Inotropes in Sepsis.
Stratton L; Berlin DA; Arbo JE
Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
[TBL] [Abstract][Full Text] [Related]
18. Inotropes.
Francis GS; Bartos JA; Adatya S
J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672
[TBL] [Abstract][Full Text] [Related]
19. Vasopressors for acute myocardial infarction complicated by cardiogenic shock.
Prondzinsky R; Hirsch K; Wachsmuth L; Buerke M; Unverzagt S
Med Klin Intensivmed Notfmed; 2019 Feb; 114(1):21-29. PubMed ID: 29204662
[TBL] [Abstract][Full Text] [Related]
20. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database.
Sasmita BR; Wang C; Xie S
Front Cardiovasc Med; 2023; 10():1300839. PubMed ID: 38094120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
